Pharmaceutical Technology

MAY 18, 2023

Amongst the recommendations are calls for informing national competent authorities of impending shortages, creating shortage prevention protocols, designing multinational supply chains to increase resilience, and communication lines between stakeholders and supply chains.

Medicine 99

Medicine Specialization Networking Patients 99

European Pharmaceutical Review

NOVEMBER 15, 2022

According to IGBA, the World Health Organization ( WHO) Biosimilars Guideline has been a useful tool for health authorities to boost international regulatory convergence and consistency of terminology when evaluating biosimilars, by approving quality, safe and efficacious biosimilar medicines for patients who otherwise would have lacked access.

Medicine 89

Medicine Safety Healthcare Healthcare 89

European Pharmaceutical Review

MAY 18, 2023

Key recommendations include: Informing national competent authorities of potential or actual medicine shortages as early as possible and providing detailed information to better predict the possible impact and implement preventive measures establishing robust shortage prevention and shortage management plans optimising pharmaceutical quality systems (..)

Medicine 89

Medicine Distribution Manufacturing Management 89

European Pharmaceutical Review

AUGUST 2, 2023

Authored by experts at Amgen, the paper asserted that delays associated with off-line analytical testing can hinder the speed of process development. Real-time monitoring and control of the biomanufacturing processes through product quality insights continues to be a key area of focus in the biopharmaceutical industry, the paper reported.

Manufacturing 92

Manufacturing Management Competition Leads 92

European Pharmaceutical Review

JANUARY 16, 2023

Interpharma, Switzerland’s research-based pharmaceutical industry association stated the agreement “…will strengthen the resilience of supply chains and therefore improve the security of supply.”. Good Manufacturing Practice for pharmaceutical drugs.

Food and Drug Administration 108

Food and Drug Administration FDA Manufacturing Food 108

European Pharmaceutical Review

JULY 21, 2023

There are four ways: Establish strong regulatory partnerships: Collaborate with regulatory authorities to establish clear guidelines, harmonise regulations, and streamline processes across different regions and countries. Going forward, it is imperative for companies to invest in constructing more resilient supply networks.

Pharmaceutical 94

Pharmaceutical Food and Drug Administration Transportation Manufacturing 94

pharmaphorum

JANUARY 18, 2023

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. About the author. Giving participants something in return.

Medicine 79

Medicine Ethics Healthcare Healthcare 79

European Pharmaceutical Review

JULY 15, 2022

Resiliency and renewables. With a comprehensive energy strategy, pharmaceutical businesses can reduce carbon emissions, maintain resilience, predict future energy costs and enhance ESG performance” Going green is not without its challenges. About the author. Conclusions.

Pharmaceutical manufacturing 91

Pharmaceutical manufacturing Manufacturing Pharmaceutical Government 91

pharmaphorum

SEPTEMBER 9, 2022

“With its heavy reliance on natural resources for product development and production, and complex supply chains with large carbon footprints, the pharmaceutical industry has been highlighted as one of the biggest contributors to global emissions,” said the authors of a whitepaper from climate intelligence specialists, Cervest. Resilience.

Distribution 88

Distribution Pharma Pharmaceutical Pharmaceutical products 88

Pharmaceutical Technology

DECEMBER 12, 2022

The European regulator extended Comirnaty’s authorized use to those between the ages of six months and four years. Aldevron LLC, Lonza Group Ltd, National Resilience Inc, and Laboratorios Farmaceuticos Rovi SA are manufacturing the biologic API for the vaccine. Regulatory and reimbursement decisions in the UK.

Manufacturing 59

Manufacturing Biopharma Pharmaceutical Pharma 59

pharmaphorum

NOVEMBER 10, 2022

Preventive and diagnostic care is key to building more inclusive and resilient systems and procedures for the healthcare sector, but we have a long way to go before this vision becomes reality. Resilient health systems have prevention at their core, and building capacity to this end is key, not simply for routine care.

Healthcare 79

Healthcare Healthcare Medicine Management 79

pharmaphorum

DECEMBER 21, 2022

Emotion – creating an open dialogue between people to boost their understanding of (and resilience to) sustainability. About the author. Mission – embedding purpose and upholding ethics across every area of a business. Innovation – using technology to solve problems without creating harmful side-effects.

Side effects 95

Side effects Ethics Healthcare Healthcare 95

pharmaphorum

SEPTEMBER 28, 2022

What we saw from the Pre-Cert pilot is that companies that invest in infrastructure around continuous integration and continuous deployment not only have more resilience to changes in terms of the updates that they push, …, but they are also able to fix problems faster when they happen,” O’Leary said.

FDA 128

FDA Medical Healthcare Provider Engineering 128

pharmaphorum

JUNE 28, 2022

In the future, the entire global health system will need to change to become more resilient, which requires many individual changes but can be broken down it smaller, logical actions that have outsized outcomes. Resilient national systems: To strengthen a critical foundation for global pandemic preparedness and response.

Government 52

Government Medical Pharma Training 52

pharmaphorum

DECEMBER 20, 2022

However, this rapidly-built infrastructure often fell short in terms of long-term sustainability and resiliency. About the author. The post Transforming healthcare through sustainable and resilient data infrastructure appeared first on.

Healthcare 95

Healthcare Healthcare Patients Electronics 95

Pharmaceutical Technology

MARCH 30, 2023

Recall powers for all drugs: The budget reveals legislative as well as spending plans; the agency wants to expand its authority to recall any drug. Device shortages and supply chain: +$11.6m, for a total of $21.6m, for the Resilient Supply Chain and Shortages Program for medical devices. ACT for ALS : +$2.5m for a total of $7.5m

Manufacturing 59

Manufacturing FDA Safety Pharma 59

Curzon Consulting

JANUARY 16, 2023

As highlighted on the chart, the best time to start a business transformation programme and build financial and operational resilience is when the yield curve is inverted and well BEFORE it straightens again (i.e. Contact Chetan Author. rises above the zero line). If you are interested in learning more, please get in touch.

Healthcare 52

Healthcare Healthcare 52

pharmaphorum

AUGUST 12, 2022

That’s a perfectly reasonable response – domestic production is much more resilient. Not only will this make domestic drug supplies resilient in an uncertain future. About the author. But reshoring is also a huge challenge given the economic, regulatory, and logistical obstacles involved. The case for inshoring is clear.

Manufacturing 57

Manufacturing Pharmaceutical Sales Government 57

Clarivate

MAY 26, 2022

Building resiliency into clinical trial protocols. Building resiliency into clinical trial protocols. Engaging regulators early and often. Strategically selecting participants and making trials patient-centric. Understanding diseases and treatments from a patient POV. Utilizing a variety of data sources to mine insights.

Marketing 52

Marketing Patients Recruitment Management 52

European Pharmaceutical Review

NOVEMBER 2, 2023

One recommendation sought the optimisation of pharmaceutical quality systems and increased resilience of complex, multinational supply chains. However, in recent months, a range of European organisations have made progress in addressing medicine shortages, through new actions, working groups and more.

Medicine 99

Medicine Manufacturing Pharmaceutical Safety 99

Clarivate

MARCH 17, 2022

SDG 1: No Poverty aims to eradicate poverty by implementing social protection systems for the poor, build resilience to environmental, economic and social disasters, ensure equal rights to ownership, basic services, technology and economic resources and more. About the authors. SDG 1: No Poverty. Photo of Prof. Marcel G.A.

Food 98

Food Engineering Specialization Education 98

pharmaphorum

JANUARY 26, 2023

Next year will likely see the first commercial projects employing precision breeding, particularly focused on developing resilient, higher-yield and drought resistant crops. About the author Neil Ward is VP and general manager for Europe, Middle East, and Africa at PacBio.

Pharmacology 115

Pharmacology Government Leads Physicians 115

European Pharmaceutical Review

APRIL 21, 2023

About the author Dorothea Baltruks is a Research Associate at the Centre for Planetary Health Policy (CPHP) where she focuses on the transformation of the German health system towards climate resilience and sustainability. The 2022 Europe report of the Lancet Countdown on health and climate change: Towards a climate resilient future.

Pharma 81

Pharma Food and Drug Administration Medicine Pharmaceutical 81

European Pharmaceutical Review

DECEMBER 19, 2023

Guaranteeing resilience in vaccine manufacturing The use of foreign materials that require removal before injection are also impracticable. About the author Dr Bruce Roser MB BS, PhD founded Stablepharma in 2012, to bring to market his important work on vaccine stabilisation.

Distribution 99

Distribution Manufacturing Food Specialization 99

Clarivate

MARCH 14, 2024

This distinctive quality imparts resilience and durability to PFAS, making them valuable for diverse industrial uses, including pharmaceutical packaging. Can we expect a comparable action to follow suit in the pharmaceutical industry in regards to primary or even secondary packaging?

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

AUGUST 23, 2022

physical resilient anti-counterfeiting method for medicines and pharmaceutical products. About the author. The second example combines digital and material properties into edible digital watermarking using inkjet printing without introducing material toxicity or cytotoxicity. This allows for a cyber?physical

Medicine 90

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 90

Salesforce

JULY 6, 2021

“Mentoring is the best tool we have for connecting a virtual workforce and for helping underrepresented employees gain connection and community in the organization,” said Jenn Labin, author of several books on mentoring , and chief diversity officer at MentorcliQ, a mentoring software platform. “It

Training 98

Training Marketing Recruitment Consulting 98

pharmaphorum

DECEMBER 29, 2022

Many have already shown remarkable responses to recent global crises, and this can build the foundation for more widespread activation of digitalisation initiatives to build resilience and ensure future business agility. About the author. Chuck Miller, director of solution consulting at Aspen Technology, Inc. received his B.A.

Manufacturing 95

Manufacturing Pharma Medicine Engineering 95

pharmaphorum

JANUARY 27, 2023

On the positive side, the string of international crises has greatly heightened public and political awareness of the need for essential medicines – primarily off-patent therapies – and for sustainably resilient supply chains. About the author Richard Saynor was appointed CEO of Sandoz in 2019, a Novartis generics and biosimilars division.

Medicine 88

Medicine Government Marketing Transportation 88

pharmaphorum

JULY 28, 2022

Building supply chain resilience. About the Author. It is an unavoidable fact that our industry requires a high level of skill and education which makes identifying and hiring talent even more difficult. Meanwhile, attitudes towards work have changed, with a greater demand for work-life balance.

Pharma 94

Pharma Consulting FDA Manufacturing 94

pharmaphorum

NOVEMBER 27, 2022

Instead, companies should be looking towards a future where speed and agility are the key components in developing business resilience, rather than a reliance on inventory stockpiles and large quality assured batches. About the author. Automation will be a large part of this long-term vision.

Pharma 101

Pharma Safety Pharmaceutical Manufacturing 101

European Pharmaceutical Review

JUNE 24, 2022

focused companies operate, and… it would also no longer be more rational for broader-portfolio companies to prioritise investments in (some) OMPs relative to other products,” wrote the authors. About the author. Maarten has significant competition law experience in a variety of sectors. References.

Pharmaceutical 98

Pharmaceutical Medicine Marketing Competition 98

pharmaphorum

JANUARY 24, 2023

2023 will therefore be a year of challenge and shakeout: what emerges to enter 2024 will be only the most innovative, agile, and above all, resilient. About the author Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry, having worked in Accenture’s pharmaceutical strategy practice prior to joining IQVIA.

Medicine 90

Medicine Healthcare Healthcare Pharma 90

Salesforce

AUGUST 1, 2022

Leaders need to be adept at vision, strategy, and execution — this has always been table stakes — but now they need to have the emotional intelligence and resilience to manage hybrid teams with widely differing needs, goals, work styles, personal situations, and more. Flexible work requires a new set of management skills.

Management 98

Management Leads Education Marketing 98

European Pharmaceutical Review

SEPTEMBER 16, 2022

We have reported several times on supply chain resilience since the start of the COVID-19 pandemic, 1-3 as the world experienced unprecedented lockdowns and supply disruptions, with interruptions to manufacturing as well as both air transportation and shipping routes. Promoting supply chain localisation.

Pharmaceutical 86

Pharmaceutical Manufacturing Pharma Transportation 86

Impetus Digital

JUNE 8, 2022

Biotech will also lead to less environmentally harmful agricultural practices as resilient crops become more efficient and targeted pesticides are used in lower volumes. About the Author. Agricultural biotech has the potential to revolutionize agriculture and investors are taking notice.

Medicine 52

Medicine FDA Leads Distribution 52

European Pharmaceutical Review

JANUARY 10, 2024

Disturbing an ecosystem can lead to loss of biodiversity, population imbalances, habitat destruction, changes in function (eg, metabolism and nutrient cycling), loss of resilience and increased vulnerability to disease.

Medicine 52

Medicine Manufacturing Leads Networking 52